CW May 2002

category image Volume 11
Issue Number 5
May 2002
ISSN 10593802

Venlafaxine is Safe to Use in Breast Cancer Patients

Venlafaxine, a newer antidepressant, is very effective in reducing the frequency and severity of hot flashes in breast cancer patients. Chemotherapeutic agents frequently cause early menopause.
Go to Previous Page
Go to Next Page

Source & Additional Reading

D. Barton, Oncology Nursing Forum, February 2002.

Purchase Downloadable Full-text PDF of Article: $10.00

Subscription is more cost effective than purchasing PDFs on-the-fly.  Click here for details.

Download Complete Issue CW May 2002

Purchase Downloadable Full-text PDF of Complete Issue: $20.00


Member Login | Home | Offices | Subscribe | Glossary | Cancer Technologies | Contact Us

Adenine Press, 2066 Central Avenue, Schenectady, NY 12304 USA
phone: 518-456-0784; fax: 518-452-4955; email: info@adeninepress.com
copyright © Adeninepress, All rights reserved.




Re-initialize IP-based Login